References
- Abbas S, Linseisen J, Slanger T, et al (2008). The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev, 17, 1339-43. https://doi.org/10.1158/1055-9965.EPI-08-0162
- Ahn J, Yu K, Stolzenberg-Solomon R, et al (2010). Genome-wide association study of circulating vitamin D levels. Hum Mol Genet, 19, 2739-45. https://doi.org/10.1093/hmg/ddq155
- Anderson LN, Cotterchio M, Cole DE, et al (2011). Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev, 20, 1708-17. https://doi.org/10.1158/1055-9965.EPI-11-0300
- Anic GM, Weinstein SJ, Mondul AM, et al (2014). Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer. PLoS One, 9, 102966. https://doi.org/10.1371/journal.pone.0102966
- Bai Y, Yu Y, Yu B, et al (2009). Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China. BMC Med Genet, 10, 125. https://doi.org/10.1186/1471-2350-10-125
- Borradale D, Kimlin M (2009). Vitamin D in health and disease: an insight into traditional functions and new roles for the 'sunshine vitamin. Nutr Res Rev, 22, 118-36.
- Chupeerach C, Tungtrongchitr A, Phonrat B, et al (2012). Association of Thr420Lys polymorphism in DBP gene with fat-soluble vitamins and low radial bone mineral density in postmenopausal Thai women. Biomarkers Med, 6, 103-8. https://doi.org/10.2217/bmm.11.88
- Engelman CD, Fingerlin TE, Langefeld CD, et al (2008). Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab, 93, 3381-8. https://doi.org/10.1210/jc.2007-2702
- Gandini S, Gnagnarella P, Serrano D, et al (2014). Vitamin D receptor polymorphisms and cancer. Adv Exp Med Biol, 810, 69-105.
- Holick MF (2007). Vitamin D deficiency. N Engl J Med, 357, 266-81. https://doi.org/10.1056/NEJMra070553
- Kidd LC, Paltoo DN, Wang S, et al (2005). Sequence variation within the 5' regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk. Prostate, 64, 272-82. https://doi.org/10.1002/pros.20204
- Mahmoudi T, Karimi K, Arkani M, et al (2014). Lack of associations between vitamin D metabolism-related gene variants and risk of colorectal cancer. Asian Pac J Cancer Prev, 15, 957-61. https://doi.org/10.7314/APJCP.2014.15.2.957
- Malik S, Fu L, Juras DJ, et al (2013). Common variants of the vitamin D binding protein gene and adverse health outcomes. Crit Rev Clin Lab Sci, 50, 1-22. https://doi.org/10.3109/10408363.2012.750262
- McCullough ML, Stevens VL, Diver WR, et al (2007). Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res, 1-9.
- Mocellin S (2011). Vitamin D and cancer: deciphering the truth. Biochim Biophys Acta, 1816, 172-8.
- National Cancer Institute of Thailand (2011). Cancer Registry.
- Oh JJ, Byun SS, Lee SE, et al (2014). Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population. Gene, 533, 86-93. https://doi.org/10.1016/j.gene.2013.09.119
- Pani MA, Regulla K, Segni M, et al (2002). A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J Clin Endocrinol Metab, 87, 2564-7.
- Poynter JN, Jacobs ET, Figueiredo JC, et al (2010). Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the colon cancer family registry. Cancer Epidemiol Biomarkers Prev, 19, 525-36. https://doi.org/10.1158/1055-9965.EPI-09-0662
- Powe CE, Evans MK, Wenger J, et al (2013). Vitamin D-Binding Protein and Vitamin D Status of Black Americans and White Americans. N Engl J Med, 369, 1991-2000. https://doi.org/10.1056/NEJMoa1306357
- Robien K, Butler LM, Wang R, et al (2013). Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore. Br J Nutr, 109, 493-502. https://doi.org/10.1017/S0007114512001675
- Santos BR, Mascarenhas LP, Boguszewski MC, et al (2013). Variations in the vitamin D-binding protein (DBP) gene are related to lower 25-hydroxyvitamin D levels in healthy girls: a cross-sectional study. Horm Res Paediatr, 79, 162-8. https://doi.org/10.1159/000348847
- Sinotte M, Diorio C, Berube S, et al (2009). Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr, 89, 634-40. https://doi.org/10.3945/ajcn.2008.26445
- Speeckaert M, Huang G, Delanghe JR, et al (2006). Biological and clinical aspects of the vitamin D binding protein (Gcglobulin) and its polymorphism. Clin Chim Acta, 372, 3-42.
- Taylor JA, Horvomen A, Watson M, et al (1996). Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res, 56, 4108-10.
- Wang TJ, Zhang F, Richards JB, et al (2010). Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet, 376, 180-8. https://doi.org/10.1016/S0140-6736(10)60588-0
- Weinstein SJ, Mondul AM, Kopp W, et al (2013). Circulating 25-hydroxyvitamin D, vitamin D binding protein, and risk of prostate cancer. Int J Cancer, 132, 2940-7. https://doi.org/10.1002/ijc.27969
- Weinstein SJ, Purdue MP, Smith-Warner SA (2014). Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the prostate, lung, colorectal and ovarian cancer screening trial. Int J Cancer, 136, 654-64
- Yu K, Yang J, Jiang Y, et al (2014). Vitamin D receptor bsmi polymorphism and colorectal cancer risk: an updated analysis. Asian Pac J Cancer Prev, 15, 4801-7. https://doi.org/10.7314/APJCP.2014.15.12.4801
- Zhang Z, He JW, Fu WZ, et al (2013). An analysis of the association between the vitamin D pathway and serum 25-hydroxyvitamin D levels in a healthy Chinese population. J Bone Miner Res, 28, 1784-92. https://doi.org/10.1002/jbmr.1926
- Zhao X, Yang B, Yu G, et al (2014). Polymorphisms in the vitamin D receptor (VDR) genes and skin cancer risk in European population: a meta-analysis. Arch Dermatol Res, 306, 545-53. https://doi.org/10.1007/s00403-014-1464-8
- Zhou L, Zhang X, Chen X, et al (2012). GC Glu416Asp and Thr420Lys polymorphisms contribute to gastrointestinal cancer susceptibility in a Chinese population. Int J Clin Exp Med, 5, 72-9.
Cited by
- Vitamin D Receptor Gene Polymorphism and the Risk of Colorectal Cancer: A Nested Case-Control Study vol.11, pp.10, 2016, https://doi.org/10.1371/journal.pone.0164648
- Polymorphisms of Vitamin D Signaling Pathway Genes and Calcium-Sensing Receptor Gene in respect to Survival of Hemodialysis Patients: A Prospective Observational Study vol.2016, pp.1687-8345, 2016, https://doi.org/10.1155/2016/2383216
- Quantification of Total Vitamin-D-Binding Protein and the Glycosylated Isoforms by Liquid Chromatography–Isotope Dilution Mass Spectrometry vol.16, pp.11, 2017, https://doi.org/10.1021/acs.jproteome.7b00560
- Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk vol.17, pp.10, 2016, https://doi.org/10.3390/ijms17101597
- SNPs related to vitamin D and breast cancer risk: a case-control study vol.20, pp.1, 2018, https://doi.org/10.1186/s13058-017-0925-3
- The GC2 haplotype of the vitamin D binding protein is a risk factor for a low plasma 25-hydroxyvitamin D concentration in a Han Chinese population vol.16, pp.1, 2019, https://doi.org/10.1186/s12986-019-0332-0